Neurotoxicity of PBDEs on the Developing Nervous System
doi:10.1289/ehp.1103907 Dingemans et al. (2011) published a review article on polybrominated diphenyl ethers (PBDEs) and the developing nervous system. However, the authors summarized but failed to criti cally evaluate the articles cited in their review. They also did not discuss or cite literature that contradicted the studies on which they based their conclusions. For example, the U.S. Environmental Protection Agency (EPA) cosponsored an expert panel on neurodevelop mental end points, which concluded that an experimental design used in nine of the studies cited by Dingemans et al. (2011) failed to control for litter effects (Holson et al. 2008) .
Although some investigators have set forth the argument that direct dosing of pups precludes the need to control for litter effects, a U.S. EPA cosponsored expert panel (Moser et al. 2005 ) evaluated this issue and concluded otherwise.
Regardless of whether Dingemans et al. (2011) view the studies by Holson et al. (2008) and Moser et al. (2005) as credible, the authors should have discussed them to some degree. It is understandable that because of space limitations not all studies can be included in a review. However, it was unacceptable to exclude studies that carry the weight of U.S. EPA cosponsored expert panels or other reviews that critically evaluated many of the studies cited by Dingemans et al. (2011 ) (e.g., Goodman 2009 Hardy et al. 2009; Williams and DeSesso 2010) and came to opposite conclusions.
Although the article by Dingemans et al. (2011) was peer-reviewed, it presents information in a selective, noncritical manner, which is best reserved for public relation pieces communicated in the non-peer-reviewed media. Banasik and Suchecka express their discontent with our recent review on the (in-)direct neurotoxic effects of parent and hydrox ylated (OH-) polybrominated diphenyl ethers (PBDEs) on the (developing) nervous system (Dingemans et al. 2011) . Their main discontent appears to be once more related to the experi mental design in a number of cited behavioral studies. However, our aim was to identify and review the mecha nisms under lying the observed adverse (behavioral) effects, not to evaluate the experimental design of behavioral studies within a regulatory setting. Nonetheless, approximately 10% of our review was dedicated to describing a number of behavioral studies [12 different studies from seven different research groups, including a 2008 EPA study (Gee and Moser 2008) ] that all indicated the occurrence of neuro behavioral effects following developmental exposure to PBDEs. We used this information to create a starting point for the main part of our review of direct and indirect cellular and molecular mechanisms. For readability and space limitations, we were not able to include all studies, concerns, or critiques that have ever been raised. The absence of a citation to a particular study does not mean that we regard it as less credible.
The view that (developmental) exposure to PBDEs induces adverse neuro toxic effects is widely supported by numerous in vivo, ex vivo, and in vitro studies reporting both structural and functional effects (Dingemans et al. 2011) . For some time, a lively discussion has been taking place within the scientific community on the experimental design for behavioral developmental neuro toxicity studies for regulatory purposes, in particular considering the statistical unit (Alcock et al. 2011 ). In short, there is disagreement about whether direct dosing of pups precludes the need to control for litter effects (e.g., Eriksson 2008; Hardy and Stedeford 2008) . However, we did not address this topic in our paper because we consider the potential occurrence of a litter effect to be irrele vant for the reviewed cellular and molecular in vitro studies, which all indicate that exposure to PBDEs induces neurotoxic effects.
Critical remarks can be found throughout our review (Dingemans et al. 2011 ), but they are related to cellu lar and molecular findings, data gaps, or aspects that warrant further investigation. Our main conclusions are related to the specific (developmental) neuro toxic hazard of OH-PBDEs compared with that of their parent congeners via direct neuro toxicity and thyroid disruption. We also pointed out the need to further investigate the impact of active metabolites, concentrations of PBDEs and metabolites in the (developing) brain, and the potentially increased neurotoxic hazard following exposure to mixtures of different environmental contaminants.
Nonetheless, Banasik and Suchecka raise an important issue: the existence of differences in experimental designs for in vivo investigation of (developmental) neuro toxicity. Differences exist in the selection of investigated end points and also in methodologies for the investigation of a specific end point, as reviewed for effects on motor activity by brominated flame retardants (Williams and DeSesso 2010) . These differences in experi-
